Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Vascular_Surgery__Cases__Questions_and_Commentaries__Third_Edition.pdf
Скачиваний:
25
Добавлен:
21.03.2016
Размер:
18.54 Mб
Скачать

53  Management of Chronic Lymphedema of the Lower Extremity

553

 

 

4.  Reconstructive surgery to restore lymph transport

5.  Excisional surgery to remove overgrown fibrosclerotic tissue (Answer – 5)

Treatment failure, despite a full year of maximum conventional care, was accepted as the indication of additional treatment by the multidisciplinary team.

Question 10

What is NOT an essential part for the treatment in such an advanced stage?

1.  Encouraging patient compliance to maintain physical therapy 2.  Multidisciplinary team approach to improve quality of life

3.  Repeated assessments of lymphatic function with lymphography 4.  Active mobilization for better social and psychological rehabilitation 5.  Vigorous control and prevention of infection (Answer – 3)

53.1  Commentary

The clinical history of this young lady illustrates how primary lymphedema progresses when timely appropriate care is neglected.

Her left lower limb swelling since the birth should have been recognized as a primary lymphedema until proven otherwise. A basic assessment of her clinical appearance should not have been delayed especially after the contralateral limb went down the same path of the swelling as a ‘precox’ type.18

It would have ideal for basic investigations to confirm primary lymphedema when both limbs got involved. Focused management combined with active prevention of infection could then have been started at a much earlier point.

With early aggressive management, her lymphedema condition would have not reached such an advanced stage so quickly with suchlife-threatening sepsis.

If lymphedema advances to a late stage, a simple edematous condition of the soft tissue becomes a fibrosclerotic one. This will then resist conventional treatments such as manual lymphaticdrainage(MLD)-basedcomplexdecongestivetherapy(CDT).914 hardenedlocal tissue becomes a harbinger for infection which often advances to systemic sepsis.

Sepsis is the most serious complication as it is a potentially life-threatening. This often leads a vicious cycle with more tissue damage and subsequent vulnerability condition to recurrent sepsis/infection.1518

This young lady is a typical example of advanced lymphedema (Fig. 53.1).

Neglect carewithout regularCDT acceleratedthedeterioration of her tissues provoking local sepsis and septic shock prior to her emergency admission

Prompt management of septic shock is warranted with appropriate resuscitation to stabilizehervitalsigns.Antibioticsshouldbegivenassoonaspossibleafterthebloodculture specimenisobtainedandcontinuedparenterallyuntilsuitableselectionofculture-sensitive

554

B.-B. Lee and J. Laredo

 

 

antibiotics. Once the patient condition is stabilized, the diagnosis of her primary condition should be initiated. For an appropriate differential diagnosis on such limb swellings, not only the local causes but also the regional and systemic causes should be included, especially if there is any doubt on currently established diagnosis.

In addition, a thorough investigation on the cause of sepsis should be repeated (e.g., fungal infection: tinea pedis). [Q1: 4]

Limbswellingsincebirthalongtheleftlowerlegandtoesandsubsequentlyontheright lower limb, gives ample evidence for primary lymphedema as her diagnosis. Nevertheless the causes of secondary lymphedema should also be ruled out regardless of age of onset.

Primary lymphedema represents a “truncular” type of lymphatic malformation (LM)1922 since the majority have associated congenital structural abnormalities of the lymphatic system (e.g., aplasia, hypoplasia, hyperplasia).

LMs are a common form of congenital vascular malformations (CVMs)2326 either as an independent (predominant) lesion or as a combined condition with other CVMs: venous malformations (VMs),2730 arterio-venous malformations (AVMs),3134 and/or capillary malformations (CMs).

The diagnosis and management of primary lymphedema should therefore consider such coexistence with other CVMs, including the extratruncular LM (e.g., Klippel-Trenaunay Syndrome)3538 (Fig. 53.2).

A basic understanding on the LM as a CVM, including its embryological background is required in order to lead appropriate investigations on primary lymphedema.

Like other CVMs, these LMs are also classified into two different groups3941 depending upon the embryological stage of developmental arrest: extratruncular and truncular LM’s.

Extratruncular LMs are also known as “lymphangiomata” – and they are embryonic tissue remnants as a result of developmental arrest/defect occurring in the “earlier” stage of lymphangiogenesis. Mesenchymal cell characteristics are maintained with the evolutionary potential to grow when stimulated (Fig. 53.3).

In contrast truncular lesions are a result of developmental arrest/defect at the “later” stage of lymphangiogenesis and lack these critical embryonic characteristics.42,43

Following stabilization from septic shock, the treatment of sepsis should start with parenteral antibiotic administration while searching for the source of the infection. Compression therapy with MLD-based CDT or a pneumatic compression device is contraindicated until the sepsis is under full control. Early ambulation is recommended to control decubitus development. [Q3: 1]

Vigorous application of high pressure compression therapy should be deferred until the cardiovascular system is fully stabilized. CDT is under close observation when the overall cardiovascular condition can afford the additional loading of mobilized edema fluid. [Q4: 4] Rapidfluidmobilizationfromamassivelyswollenlimbisdangeroussoonaftersepticshock. If the forceful evacuation of fluid from the interstitialspace is too effective, massive influx into

the intravascular space will accompany a high risk of acute pulmonary edema. [Q5:3]

Inordertoprovideanappropriatetreatmentstrategyforlongtermcare,afullassessment canbeachievedbasedonacombinationofbasicnon-toless-invasivetests4446:Radionuclide lymphoscintigraphy (LSG),4749 Duplex ultrasonographic assessment,5052 Limb volume measurement,5355 and Magnetic Resonance Imaging (MRI) study.5658 Although the MRI is NOT essential for the investigation of primary lymphedema caused by the truncular LM

53  Management of Chronic Lymphedema of the Lower Extremity

555

 

 

a b

Fig. 53.2  The clinical photo (a) belonging to another patient shows typical appearance of KlippelTrenaunay syndrome (KTS) involving the left lower extremity; entire left lower limb swelling is not only due to the primary lymphedema caused by the lymphatic malformation (LM) but also by coexisting venous malformation (VM) as well. MR Image (b) depicts typical soft tissue swelling along the lower limb as a hall mark of the chronic lymphedema. However, as the whole body blood pool scintigraphy (c) demonstrates, there are two VM lesions, truncular-marginal veinas well as extratruncular VM involving to the left lower limb to accentuate the swelling. The radionuclide lymphoscintigraphy(d)confirmsadvancedlymphaticdysfunctionduetotheprimarylymphedema, displaying extensive dermal backflow along the left lower limb due to a lack of normal clearance condition/lymphatic transportation. Therefore, whenever the “primary” lymphedema is encountered as the cause of limb swelling, possible coexisting of another congenital vascular malformations(CVMs)shouldberuledoutfirst.Because,themajorityoftheprimarylymphedemarepresents the clinical manifestation of the truncular LM

556

B.-B. Lee and J. Laredo

 

 

Fig. 53.2  (continued)

c

d

itself, the MRI may give not only additional information on the lymphedema status as well as coexisting CVMs like extratruncular VM’s and/or LM’s. [Q6: 1]

Oil contrast lymphography59,60 is invasive and not needed for the diagnosis. Due to the risk of further damaging the lymph vessels it’s use is now strictly limited as a special indication for the selection of surgical reconstruction candidates.

Suchinvestigationstoprovidethecriticalinformationneededtosetupaadequatehome maintenance care regimen following discharge from acute care.

Accurate information on the clinical and laboratory stage of the lymphedema46,61 is important for the selection of the right therapy. Abnormalities of the deep venous system would affect the response to therapy. Coexisting CVMs may also give a profound impact to the overall management.

Finally, an accurate evaluation on self-motivation to maintain care is absolutely essential since the life-time commitment to CDT based home maintenance therapy is totally depending on patient compliance.18,44 [Q7: 3]

53 

Management of Chronic Lymphedema of the Lower Extremity

557

 

 

 

a

b

 

Fig. 53.3  Clinical photo (a) shows diffuse swelling along the upper thigh extended to the groin, which is due to the extratruncular LM, different from the truncular LM causing the primary lymphedema. This extratruncular LM, often called as “lymphangioma,” is the outcome of developmental arrest/defect from the “early” stage of lymphangiogenesis. Therefore, it possesses a mesenchymal cell characteristic to grow when the condition should meet (e.g., hormone, menarche, pregnancy, trauma, surgery). As shown in MRI (b), this extratruncular lesion in upper thigh is extended to the pelvic cavity affecting entire pelvic soft tissue and the left lower limb lesion/swelling is a tip of the iceberg. The lesion is now complicated with the lymphatic leakage and sepsis

CDT914 remains a main stay of contemporary treatment of chronic lymphedema although it does not cure the condition. It is the most effective means to prevent the progress of the condition. Among various components of CDT, MLD is the most essential part together with compression bandage.62,63 MLD is a physiological means to stimulate paralyzed lymph vessels to restore peristalsis and relieve lymph stasis. Although MLD lacks theoretical evidence, it is now accepted as an effective therapy in the early stages of lymphedema (Fig. 53.4).

Incontrastthesequentialpneumaticcompression-therapy(SIPC)6466 remainscontroversial due to risk of selective transfer of the fluid component out of the interstitial tissue leaving the protein component of the lymph behind to precipitate progressive tissue damage.

Among the many different components of CDT, compression bandage therapy remains the most effective and proven component. These recommendations are based on the grading according to scientific evidence,67 where compression therapy belongs to 1C or 2A. 1C

558

B.-B. Lee and J. Laredo

 

 

represents a strong recommendation based on low-quality evidence where as 2A is a weak recommendation based on high-quality evidence (Table 53.1). [Q8: 2]

However, when CDT-based conservative therapy fails, despite maximum care, surgical therapy is generally considered as a supplemental regimen to improve its efficacy of the

CDT.68,69

Reconstructivesurgery7074 isgenerallyaimedattheearlystagesofthelymphedemawhere the paralyzed lymph vessels can be rescued before they become permanently damaged by chronic lymphatic hypertension. Methods to repair a damaged lymph transport system and restore lymphatic function include lymphatico-venous anastomosis, lymphatico-lymphatic bypass, lymphatico-lymphatic segmental interposition, and free lymph node transplantation.

a

b

Fig. 53.4  Two clinical photos (a and b) show a clinical condition of another/different patient with primary lymphedema before (a) and after (b) the CDT instituted, showing how effective this MLDbased CDT is. As displayed by the radionuclide lymphoscintigraphy (LSG) (c and d), the pre-CDT LSG (c) shows extensive dermal backflow due to the lymph stasis in the soft tissue while the postCDT LSG (d) demonstrates excellent response of the lymph stasis to the CDT

53  Management of Chronic Lymphedema of the Lower Extremity

559

 

 

Fig. 53.4  (continued)

c

 

d

In advanced lymphedema however, there are no more salvageable lymphatic vessels remaining and therefore, it is too late for reconstructive surgery.

Since overgrown fibrosclerotic tissue is a known harbinger for t recurrent sepsis (e.g., cellulitis/erysipelas) (Fig. 53.5). Excisional surgery18,44,75 and 76 would improve not only the efficacy of CDT but also the overall risk of sepsis thereby improving quality of life. Although surgery remains as a valid option to assist CDT, current evidence-based recommendations still classify this as 2C (Table 53.2).

Liposuction77,78 obliterates the epifascial compartment by a selective removal of excessive adipose tissue. This procedure is not indicated for advanced lymphedema. In end stage lympedema entire tissues become fibrosclerotic with very limited fat tissue available for liposuction.

Therefore, excisional surgery remains the only viable option among the various surgical treatment modalities in end stage disease. All candidates for the excisional surgery, require mandatory postoperative CDT with a life-time. The guarantee of satisfactory outcome of the surgery should not be expected without appropriate postoperative CDT.18,44

[Q9: 5]

This patient met the indication for excisional surgery in order to improve the efficacy of CDT, this followed the documented failure of CDT alone despite maximum care for 2

560 B.-B. Lee and J. Laredo

Table 53.1  Guidelines 6.3.0 of the American venous forum on lymphedema: medical and physical therapy

No.

Guideline

Grade of recommendation

Grade of evidence

 

 

 

(1, we recommend; 2, we

(A, high quality;

 

 

 

suggest)

B, moderate

 

 

 

 

quality; C, low or

 

 

 

 

very low quality)

6.3.1

To reduce lymphedema we recom-

1

B

 

mend multimodal complex deconges-

 

 

 

tive therapy that includes manual

 

 

 

lymphatic drainage; multilayer

 

 

 

short-stretch bandaging; remedial

 

 

 

exercise; skin care; and instruction in

 

 

 

long-term management

 

 

6.3.2

To reduce lymphedema, we recommend

1

B

 

short-stretch bandages that remain in

 

 

 

place for longer than 22 h/day

 

 

6.3.3

To reduce lymphedema we recom-

1

B

 

mend treatment daily, a minimum of 5

 

 

 

days per week, and continue until

 

 

 

normal anatomy or a volumetric

 

 

 

plateau is established

 

 

6.3.4

To reduce lymphedema we suggest

2

C

 

compression pumps in some patients

 

 

6.3.5

For maintenance of lymphedema we

1

A

 

recommend an appropriately fitting

 

 

 

compression garment

 

 

6.3.6

For maintenance of lymphedema in

1

B

 

patients with advanced (stages II

 

 

 

or III) disease we recommend using

 

 

 

short-stretch bandages during the

 

 

 

night. Alternatively, compression

 

 

 

devices may substitute for

 

 

 

short­

-stretch bandages

 

 

6.3.7

For remedial exercises we recommend

1

C

 

wearing compression garments or

 

 

 

bandages

 

 

6.3.8

For cellulitis or lymphangitis we

1

A

 

recommend antibiotics with superior

 

 

 

coverage of Gram-positive cocci,

 

 

 

particularly streptococci. Examples

 

 

 

include cephalexin, penicillin,

 

 

 

clindamycin, cefadroxii

 

 

6.3.9

For prophylaxis of cellulitis in patients

1

C

 

with more than three episodes of

 

 

infection we recommend antibiotics with superior coverage of Grampositive cocci, particularly streptococci, at full strength for 1 week/ month, Examples include cephalexin, penicillin, clindamycin, cefadroxil

53  Management of Chronic Lymphedema of the Lower Extremity

561

 

 

a

b

Fig. 53.5  Twoclinicalphotos(aandb)depictextensivecellulitisinvolvingtwodifferentsitesofthe limb through recurrent episodes. This condition is potentially life threatening condition to warrant immediate control to prevent systemic sepsis. Along the end stage of the lymphedema, such recurrent infections become a major challenge and would become an indirect indication for the excisional surgery to reduce the fibrosclerotic tissue as a major harbinger of the recurrent infection

Table 53.2  Guidelines 6.4.0 of the American venous forum on principles of surgical treatment of chronic lymphedema

No.

Guideline

Grade of recommendation

 

 

(1, we recommend; 2, we

 

 

suggest)

Grade of evidence (A, high quality; B, moderate quality; C, low or very low quality)

6.4.1 All interventions for chronic

1

C

lymphedema should be preceded by

 

 

at least 6 months of non-operative

 

 

compression treatment

 

 

6.4.2 We suggest excisional operations or

2

C

liposuction only to patients with

 

 

late stage non-pitting lymphedema,

 

 

who fail conservative measures

 

 

6.4.3 We suggest microsurgical

2

C

lymphatic reconstructions in

 

 

centers of excellence for selected

 

 

patients with secondary lym-

 

 

phedema, if performed early in the

 

 

course of the disease

 

 

 

 

 

562

B.-B. Lee and J. Laredo

 

 

years. A modified Homan-Auchincloss procedure79,80 was implemented to remove, the entire skin and soft tissues including the muscle fascia, to facilitate lymph absorption through the deep system. An excellent surgical outcome was maintained with a postoperative CDT regimen during the follow up period of 4 years (Fig. 53.6).

A multidisciplinary team approach should always be organized to support surgical therapy. This should improve quality of life provided patient compliance is good enough for maintenance CDT.

Active mobilization for better social and psychological rehabilitation should accompany CDT in order to provide an incentive to the patient to remain on therapy.

Vigorouscontrolandpreventionofinfectionshouldalwaysremaintheultimategoalfor end stage lymphedema. [Q10: 3]

a

b

Fig. 53.6  (a) photo illustrates the magnitude of the excisional surgery to remove entire soft tissue together with the skin, which all became sclerotic; Homan-Auchincloss technique was modified and excision was further extended to remove the muscle fascia as well to promote the absorption of the lymph by the deep lymphatic system. (b) photo demonstrates the surgical specimen showing the staging excision for the optimum amount of the tissue removal. Clinical photo (c) shows clinical outcome of the surgery 6 months later, achieving the goal of effective mobilization from the bed and increased efficacy of the postoperative CDT. This approach delivered improved quality of life with better social/physical/ psychological adaptation

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]